BR112014001049A2 - método para a produção de um antígeno viral derivado de vírus envelopado, e, uso de um método para a fabricação de uma preparação de vacina contendo o antígeno viral - Google Patents

método para a produção de um antígeno viral derivado de vírus envelopado, e, uso de um método para a fabricação de uma preparação de vacina contendo o antígeno viral

Info

Publication number
BR112014001049A2
BR112014001049A2 BR112014001049A BR112014001049A BR112014001049A2 BR 112014001049 A2 BR112014001049 A2 BR 112014001049A2 BR 112014001049 A BR112014001049 A BR 112014001049A BR 112014001049 A BR112014001049 A BR 112014001049A BR 112014001049 A2 BR112014001049 A2 BR 112014001049A2
Authority
BR
Brazil
Prior art keywords
viral antigen
manufacture
production
preparation containing
vaccine preparation
Prior art date
Application number
BR112014001049A
Other languages
English (en)
Portuguese (pt)
Inventor
Jacoba Van Rooij Geertje
Thus Jo
Van't Hof Ron
Shaker Sabah
cui Yi-qing
Wang Yiding
Original Assignee
Abbott Biologicals Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Biologicals Bv filed Critical Abbott Biologicals Bv
Publication of BR112014001049A2 publication Critical patent/BR112014001049A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR112014001049A 2011-07-20 2012-07-04 método para a produção de um antígeno viral derivado de vírus envelopado, e, uso de um método para a fabricação de uma preparação de vacina contendo o antígeno viral BR112014001049A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161509630P 2011-07-20 2011-07-20
EP11174660 2011-07-20
PCT/EP2012/063045 WO2013010797A1 (en) 2011-07-20 2012-07-04 Process for producing viral antigen and vaccines

Publications (1)

Publication Number Publication Date
BR112014001049A2 true BR112014001049A2 (pt) 2017-02-21

Family

ID=45094875

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014001049A BR112014001049A2 (pt) 2011-07-20 2012-07-04 método para a produção de um antígeno viral derivado de vírus envelopado, e, uso de um método para a fabricação de uma preparação de vacina contendo o antígeno viral

Country Status (12)

Country Link
EP (1) EP2734619B1 (enExample)
JP (1) JP6275641B2 (enExample)
KR (2) KR20140038530A (enExample)
CN (1) CN103827296B (enExample)
AU (1) AU2012286098C1 (enExample)
BR (1) BR112014001049A2 (enExample)
CA (1) CA2841604C (enExample)
ES (1) ES2653197T3 (enExample)
MX (1) MX2014000753A (enExample)
RU (1) RU2565827C2 (enExample)
TW (1) TW201311896A (enExample)
WO (1) WO2013010797A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109568573A (zh) * 2014-12-12 2019-04-05 普莱柯生物工程股份有限公司 疫苗组合物及其制备方法和应用
AU2018390797B2 (en) 2017-12-19 2025-10-02 CSL Behring Lengnau AG Protein purification and virus inactivation with alkyl glycosides
JP7360594B2 (ja) * 2017-12-28 2023-10-13 共立製薬株式会社 ワクチン製剤、並びに魚類のイリドウイルス感染症予防方法
US11690907B2 (en) 2018-06-12 2023-07-04 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
US11529413B2 (en) 2018-06-12 2022-12-20 Kbio Holdings Limited Virus and antigen purification and conjugation
US11485956B2 (en) 2018-06-12 2022-11-01 Kbio Holdings Limited Virus and antigen purification and conjugation
US11696948B2 (en) 2018-06-12 2023-07-11 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
JP2021528999A (ja) * 2018-07-04 2021-10-28 プロバイオジェン アーゲー エンベロープウイルスの精製方法
EP3880806A1 (en) 2018-11-15 2021-09-22 Bayer HealthCare, LLC Viral inactivation methods for continuous manufacturing of antibodies
RU2710239C1 (ru) * 2019-06-14 2019-12-25 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства Способ получения антигена или антигенов для производства противогриппозной вакцины и вакцина на его основе
KR20220098370A (ko) * 2019-11-07 2022-07-12 세퀴러스 유케이 리미티드 감소된 입자 크기를 가지는 바이러스 백신을 제조하기 위한 조성물 및 방법
JP7779858B2 (ja) * 2020-04-29 2025-12-03 エスケー バイオサイエンス カンパニー リミテッド 使い捨て培養工程システムを用いたインフルエンザウイルス生産方法及びインフルエンザウイルス抗原精製条件の迅速確認試験
KR102546626B1 (ko) * 2020-04-29 2023-06-21 에스케이바이오사이언스(주) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험
CN112309502B (zh) * 2020-10-14 2024-09-20 深圳市新合生物医疗科技有限公司 一种计算肿瘤新抗原负荷的方法及系统
JP2023141423A (ja) * 2022-03-24 2023-10-05 国立大学法人 東京大学 ウイルスの精製方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
US4240762A (en) * 1979-03-12 1980-12-23 Johnston Pump Company Seal-aligning rigid coupling assembly
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
CA2807534A1 (en) * 2003-02-25 2005-02-17 Medimmune Vaccines, Inc. Methods of producing influenza vaccine compositions
RU2283139C1 (ru) * 2005-03-21 2006-09-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Способ получения антигенов для вакцины против вирусов гриппа
EP1982727A1 (en) * 2007-04-17 2008-10-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for purification of viral proteins
US8497112B2 (en) * 2007-08-28 2013-07-30 Baxter International Inc. Method for producing viral vaccines
ES2535101T3 (es) * 2008-03-18 2015-05-05 Novartis Ag Mejoras en la preparación de antígenos en vacuna de virus de la gripe
CA2738024A1 (en) * 2008-09-24 2010-04-01 Medimmune, Llc Methods for purification of viruses
BRPI0919252A2 (pt) * 2008-09-24 2015-08-11 Medimmune Llc Métodos para cultivar células, propagação e purificação de vírus
GB0918830D0 (en) * 2009-10-27 2009-12-09 Glaxosmithkline Biolog Niederl Process

Also Published As

Publication number Publication date
MX2014000753A (es) 2014-05-07
KR20160096215A (ko) 2016-08-12
CA2841604A1 (en) 2013-01-24
JP6275641B2 (ja) 2018-02-07
CN103827296B (zh) 2016-11-16
AU2012286098C1 (en) 2016-09-15
RU2014101484A (ru) 2015-07-27
CN103827296A (zh) 2014-05-28
TW201311896A (zh) 2013-03-16
CA2841604C (en) 2020-01-21
EP2734619A1 (en) 2014-05-28
RU2565827C2 (ru) 2015-10-20
WO2013010797A1 (en) 2013-01-24
ES2653197T3 (es) 2018-02-06
EP2734619B1 (en) 2017-09-06
KR20140038530A (ko) 2014-03-28
AU2012286098A1 (en) 2014-01-23
JP2014524747A (ja) 2014-09-25

Similar Documents

Publication Publication Date Title
BR112014001049A2 (pt) método para a produção de um antígeno viral derivado de vírus envelopado, e, uso de um método para a fabricação de uma preparação de vacina contendo o antígeno viral
IL262123A (en) Influenza virus vaccines and uses thereof
HUS2100024I1 (hu) Izoxazolint tartalmazó parazita-ellenes készítmények, ezek elõállítása és alkalmazása
IL232780A0 (en) Influenza virus vaccines and uses thereof
HUE053545T2 (hu) Humán immundeficiencia vírus semlegesítõ antitestek és eljárások alkalmazásukra
BR112015002981A2 (pt) vacina estável em meio líquido, e, métodos para vacinação de um canino, e para fabricar a vacina estável em meio líquido
BR112013020070A2 (pt) moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas
DK3424532T3 (da) Influenzavirus-antistofsammensætninger
EP2680885B8 (en) Combination vaccines with lower doses of antigen and/or adjuvant
IL232976A0 (en) Antibodies binding influenza a virus epitopes, compositions comprising the same and methods of producing same
BR112015002091A2 (pt) método para a produção de um polipeptídeo, polipeptídeo, uso de um polipeptídeo e composição
BR112014001346A8 (pt) composto nanotransportador, método, composto farmacêutico e uso de um composto
BR112014003802A2 (pt) composto, composto composição farmacêutica, uso de um composto, método para fabricar um composto, e, preparação de um medicamento
EP2753345A4 (en) POLYPEPTIDIMPFSTOFF
HUE049629T2 (hu) Adeno-asszociált vírus virionok kapszid variánssal és eljárások alkalmazásukra
CO6811814A2 (es) Vacuna de virus dengue inactivado
BR112014010545A2 (pt) composição farmacêutica, método para tratar um paciente infectado com vírus da hepatite c, uso de uma composição
SG11201402780UA (en) Influenza a virus specific antibodies
IL240936B (en) Reassortment of influenza virus and methods for their preparation
EP2670843A1 (en) Multivalent vaccines for rabies virus and filoviruses
PT2575872T (pt) Concentração de antigénios da vacina da gripe sem liofilização
BR112015022347A2 (pt) composição para vacinação, método para produzir uma composição para vacinação e uso de composição
BR112013031575A2 (pt) composto peptídico ciclado de estrutura principal, composição farmacêutica, uso de composto, e, processo para a manufatura de um composto.
EP2742058C0 (en) ANTI-IL-6 VACCINE COMPOSITION
CL2013001219A1 (es) Metodo para producir virus monoglucosilado de influenza; virus monoglucosilado del antígeno de influenza ha (virus completo o recombinante); uso del virus para preparar vacuna.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)